Profile data is unavailable for this security.
About the company
Solventum Corporation is a global healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer needs. The Company’s segments include MedSurg, Dental Solutions, and Health Information System. MedSurg is a provider of solutions including negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies Original Equipment Manufacturer (OEM). Dental Solutions is a provider of a comprehensive suite of dental and orthodontic products including brackets, aligners, and restorative cement. Health Information Systems provides healthcare systems with software solutions, including computer-assisted physician documentation, and direct-to-bill and coding automation.
- Revenue in USD (TTM)8.40bn
- Net income in USD1.52bn
- Incorporated2023
- Employees22.00k
- LocationSolventum CorpC/O 3M Company3M Center, Building 275-6W-02ST. PAUL 55144-1000United StatesUSA
- Phone+1 (651) 733-1110
- Fax+1 (302) 636-5454
- Websitehttps://www.solventum.com/en-us/home/
More ▼
Mergers & acquisitions
| Acquired company | SOLV:NYQ since announced | Transaction value |
|---|---|---|
| Acera Surgical Inc | 3.17% | 850.00m |
Data delayed at least 15 minutes, as of Feb 12 2026 16:40 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Henry Schein Inc | 12.94bn | 391.00m | 9.62bn | 25.00k | 25.81 | 2.88 | 13.62 | 0.7433 | 3.17 | 3.17 | 104.73 | 28.35 | 1.19 | 4.86 | 7.60 | 517,520.00 | 3.70 | 5.43 | 6.36 | 9.19 | 31.19 | 30.23 | 3.10 | 3.98 | 0.7885 | 6.59 | 0.3872 | 0.00 | 2.71 | 4.88 | -6.25 | -11.06 | 19.66 | -- |
| Baxter International Inc | 11.02bn | -355.00m | 11.45bn | 38.00k | -- | 1.58 | 18.09 | 1.04 | -0.6925 | -0.6654 | 21.46 | 14.09 | 0.4618 | 3.14 | 6.08 | 290,078.90 | -1.48 | -0.8441 | -1.87 | -1.03 | 35.05 | 38.63 | -3.20 | -2.03 | 1.18 | 3.42 | 0.5684 | -- | 2.66 | -1.31 | -293.68 | -- | -8.52 | 1.60 |
| Revvity Inc | 2.86bn | 239.88m | 11.46bn | 11.00k | 48.81 | 1.58 | 17.76 | 4.01 | 2.07 | 2.08 | 24.49 | 63.95 | 0.2326 | 3.46 | 4.15 | -- | 1.95 | 3.23 | 2.13 | 3.58 | 54.77 | 58.48 | 8.40 | 13.58 | 1.40 | 5.23 | 0.3075 | 8.52 | 3.67 | -5.47 | -15.26 | -19.91 | -1.05 | 0.00 |
| Globus Medical Inc | 2.77bn | 423.78m | 11.81bn | 5.30k | 28.52 | 2.70 | 16.87 | 4.26 | 3.09 | 3.09 | 20.09 | 32.68 | 0.5441 | 1.29 | 4.59 | 522,604.50 | 8.32 | 4.70 | 9.53 | 5.18 | 65.34 | 66.40 | 15.30 | 9.73 | 2.47 | 15.96 | 0.0002 | 0.00 | 60.62 | 26.25 | -16.19 | -7.88 | 10.29 | -- |
| Penumbra Inc | 1.33bn | 164.03m | 13.27bn | 4.50k | 81.62 | 9.75 | 73.14 | 9.95 | 4.14 | 4.14 | 33.63 | 34.70 | 0.8276 | 1.07 | 7.42 | 296,399.60 | 10.18 | 1.42 | 11.31 | 1.58 | 66.80 | 63.21 | 12.30 | 1.96 | 4.18 | -- | 0.0171 | 0.00 | 12.86 | 16.89 | -84.59 | -21.98 | -0.853 | -- |
| Guardant Health Inc | 902.57m | -398.79m | 13.86bn | 2.00k | -- | -- | -- | 15.36 | -3.21 | -3.21 | 7.27 | -2.84 | 0.6411 | 4.02 | 8.85 | 451,510.30 | -28.33 | -24.20 | -33.49 | -26.83 | 63.76 | 63.23 | -44.18 | -91.24 | 3.12 | -10.70 | 1.47 | -- | 31.04 | 28.08 | 8.98 | -- | 10.58 | -- |
| Solventum Corp | 8.40bn | 1.52bn | 14.13bn | 22.00k | 9.37 | 2.83 | 6.91 | 1.68 | 8.69 | 8.69 | 48.01 | 28.75 | 0.5851 | 3.85 | 7.91 | 381,909.10 | 10.61 | -- | 13.32 | -- | 54.18 | -- | 18.13 | -- | 1.14 | 1.76 | 0.5075 | -- | 0.6954 | -- | -64.41 | -- | -- | -- |
| Align Technology Inc | 4.03bn | 410.35m | 14.17bn | 20.95k | 34.90 | 3.50 | 34.56 | 3.51 | 5.66 | 5.66 | 55.58 | 56.43 | 0.6483 | 5.33 | 3.85 | -- | 6.59 | 8.11 | 9.67 | 11.97 | 68.25 | 70.40 | 10.17 | 12.31 | 1.24 | -- | -- | -- | 0.899 | 10.30 | -2.61 | -25.40 | -- | -- |
| Cooper Companies Inc | 4.09bn | 374.90m | 16.28bn | 15.00k | 44.32 | 1.97 | 21.63 | 3.98 | 1.87 | 1.87 | 20.46 | 42.06 | 0.3312 | 1.71 | 5.29 | 272,826.70 | 3.03 | 8.04 | 3.32 | 8.86 | 65.54 | 66.01 | 9.16 | 24.66 | 1.13 | 6.32 | 0.2332 | 0.2049 | 5.06 | 10.98 | -4.44 | 9.48 | 3.15 | -- |
| Hologic Inc | 4.13bn | 543.80m | 16.76bn | 7.07k | 31.16 | 3.19 | 19.97 | 4.06 | 2.41 | 2.41 | 18.28 | 23.51 | 0.4608 | 2.57 | 6.79 | 583,663.40 | 6.07 | 11.22 | 6.82 | 12.85 | 56.51 | 60.20 | 13.18 | 21.99 | 3.32 | 15.76 | 0.3246 | 0.00 | 1.74 | 1.66 | -28.35 | -12.69 | -0.5168 | -- |
| Insulet Corp | 2.52bn | 246.20m | 17.65bn | 3.90k | 72.78 | 12.75 | 52.88 | 7.00 | 3.45 | 3.45 | 34.85 | 19.68 | 0.833 | 1.62 | 6.02 | 646,641.00 | 8.13 | 6.00 | 10.05 | 7.03 | 71.46 | 67.05 | 9.76 | 9.22 | 2.18 | 27.39 | 0.423 | 0.00 | 22.07 | 22.92 | 102.76 | 104.84 | -4.75 | -- |
| West Pharmaceutical Services Inc | 3.02bn | 491.70m | 17.71bn | 10.60k | 36.47 | 5.80 | 27.49 | 5.87 | 6.75 | 6.75 | 41.41 | 42.44 | 0.7757 | 4.63 | 5.13 | 284,707.60 | 12.32 | 15.61 | 14.46 | 18.70 | 35.58 | 38.00 | 15.88 | 18.84 | 2.18 | -- | 0.0638 | 10.20 | -1.92 | 9.48 | -16.97 | 15.31 | 24.43 | 5.84 |
| Illumina Inc | 4.34bn | 850.00m | 17.78bn | 8.97k | 21.30 | 6.53 | 24.70 | 4.09 | 5.46 | 5.46 | 27.84 | 17.82 | 0.6709 | 2.61 | 5.41 | -- | 13.13 | -10.15 | 17.32 | -12.15 | 66.61 | 65.39 | 19.57 | -23.18 | 1.72 | -- | 0.4221 | -- | -0.6633 | 6.04 | 169.50 | 5.32 | -- | -- |
| Zimmer Biomet Holdings Inc | 8.23bn | 705.00m | 18.95bn | 17.00k | 26.96 | 1.49 | 10.53 | 2.30 | 3.55 | 3.55 | 41.42 | 64.11 | 0.3703 | 1.10 | 5.17 | -- | 3.17 | 3.03 | 3.58 | 3.46 | 69.71 | 71.01 | 8.56 | 9.10 | 1.10 | 4.74 | 0.3718 | 29.10 | 7.20 | 6.08 | -21.98 | -- | 9.26 | 0.00 |
Data as of Feb 12 2026. Currency figures normalised to Solventum Corp's reporting currency: US Dollar USD
41.98%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2025 | 15.74m | 9.08% |
| Independent Franchise Partners LLPas of 31 Dec 2025 | 15.36m | 8.85% |
| Trian Fund Management LPas of 30 Sep 2025 | 8.46m | 4.88% |
| BlackRock Fund Advisorsas of 30 Sep 2025 | 7.43m | 4.28% |
| SSgA Funds Management, Inc.as of 30 Sep 2025 | 6.22m | 3.59% |
| Davis Selected Advisers LPas of 31 Dec 2025 | 6.22m | 3.59% |
| Boston Partners Global Investors, Inc.as of 30 Sep 2025 | 4.63m | 2.67% |
| Geode Capital Management LLCas of 30 Sep 2025 | 3.83m | 2.21% |
| Invesco Capital Management LLCas of 30 Sep 2025 | 2.81m | 1.62% |
| Diamond Hill Capital Management, Inc.as of 31 Dec 2025 | 2.11m | 1.22% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
